News
Allopurinol proves noninferior to febuxostat for gout relief
A randomized, treat-to-target trial showed that the two urate-lowering therapies were comparably effective and safe at doses titrated to target,...
News
When a JAK inhibitor fails for a patient with RA, what’s next?
Cycling to a second JAK inhibitor and switching to a biologic disease-modifying antirheumatic drug were equally effective at ameliorating...
News
Genotype, need for transfusion predict death in VEXAS syndrome
Among patients with a methionine-to-valine substitution in the UBA1 gene, survival was significantly worse, compared with patients with two other...
News
Rituximab improves systemic sclerosis skin, lung symptoms
Patients who took rituximab in the DESIRES trial had better skin scores and lung function at 6 months than did patients who received placebo.
News
Vitamin D and omega-3 supplements reduce autoimmune disease risk
“People who are otherwise healthy and have a family history of autoimmune disease might also consider starting to take these supplements.”
News
Skin checks reduce all-cause but not melanoma-specific deaths
Routine skin checks, a surrogate for skin-cancer screening, did not outperform patient self-examination at detecting lesions.
News
Convenience, not outcomes may drive robot-assisted surgeries
The sale of robotically assisted surgical devices is expected to reach $14 billion by 2028. The technology is enticing to both surgeons and...
News
A single text message links CRC patients to valuable resources
The Colorectal Cancer Provider Outreach Program, CRC POP, helps bridge the gap between a colorectal cancer diagnosis and the first treatment...
News
No short-term death risk in elderly after COVID-19 vaccines
Early reports of deaths shortly after mRNA-based vaccination of very frail elderly patients in Norway prompted a nationwide safety study.
News
Omega-3s tame inflammation in elderly COVID-19 patients
Those who received an intravenous infusion had significant decreases from baseline to end of treatment in the neutrophil-to-lymphocyte ratio.